Rehan Verjee
Director/Board Member at TYRA BIOSCIENCES, INC.
Net worth: - $ as of 2024-03-30
Profile
Rehan Verjee currently works at Precede Biosciences, Inc., as President, Chief Executive Officer & Director, Massachusetts Biotechnology Council, as Director, and Tyra Biosciences, Inc., as Independent Director from 2021.
Mr. Verjee also formerly worked at EMD Serono Canada, Inc., as Managing Director, Merck KGaA, as Global Head-Innovative Medicine Franchises, EMD Serono, Inc., as President from 2018 to 2021, and Merck KGaA, as Chief Marketing & Strategy Officer-Healthcare.
Mr. Verjee received his graduate degree from the University of Oxford.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TYRA BIOSCIENCE, INC
-.--% | 2024-03-25 | 0 ( -.--% ) | - $ | 2024-03-30 |
Rehan Verjee active positions
| Companies | Position | Start |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Director/Board Member | 2021-05-31 |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Director/Board Member | - |
Precede Biosciences, Inc.
 Precede Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Precede Biosciences is a company that aims to improve success rates in drug development and clinical practice by breaking down the barriers to precision medicine. The company is based in Boston, MA. The company seeks to redefine what can be learned from a simple blood draw to better target medicines to the right patients. Precede Biosciences is revolutionizing precision medicine by revealing unprecedented insights into disease-defining biology from a simple blood test. The CEO of the company is Rehan Verjee. | Chief Executive Officer | - |
Former positions of Rehan Verjee
| Companies | Position | End |
|---|---|---|
| MERCK KGAA | Corporate Officer/Principal | 2021-02-28 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | President | 2021-02-28 |
| EMD Serono Canada, Inc. | Chief Executive Officer | - |
Training of Rehan Verjee
| University of Oxford | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MERCK KGAA | Health Technology |
| TYRA BIOSCIENCES, INC. | Health Technology |
| Private companies | 4 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Commercial Services |
| EMD Serono Canada, Inc. | |
Precede Biosciences, Inc.
Precede Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Precede Biosciences is a company that aims to improve success rates in drug development and clinical practice by breaking down the barriers to precision medicine. The company is based in Boston, MA. The company seeks to redefine what can be learned from a simple blood draw to better target medicines to the right patients. Precede Biosciences is revolutionizing precision medicine by revealing unprecedented insights into disease-defining biology from a simple blood test. The CEO of the company is Rehan Verjee. | Commercial Services |
- Stock Market
- Insiders
- Rehan Verjee
